What Is the First-Line Treatment for Lupus Profundus?

Clinical Scenario

This protocol covers the first-line systemic treatment of Lupus profundus — a form of cutaneous lupus erythematosus (CLE) presenting with severe or widespread skin lesions, including cases where scarring and progression to systemic disease are concerns.

Treatment Approach

Antimalarial therapy is recommended as the cornerstone of first-line and long-term systemic treatment, particularly in patients with severe or widespread cutaneous involvement and those at elevated risk of scarring.

In cases of severe or widespread active lesions, antimalarial treatment is combined with systemic therapy to achieve disease control.

The full protocol — including agent selection, dosing parameters, combination sequencing, and the approach for patients with contraindications to standard antimalarials — is available in the complete structured regimen below.